T he recent spectacular progress in the treatment of coronary artery disease has led to a growing awareness of the contractile abnormalities that accompany ischemia and reperfusion. Myocardium subjected to low coronary flow exhibits a reversible decrease in the force of contraction, a phenomenon known as "hibernation." A different sort of contractile dysfunction, "stunning," prevails during reperfusion after brief periods of ischemia: force development remains impaired for days despite the maintenance of histological integrity. Unfortunately, our understanding of perfusion-related contractile dysfunction remains quite limited, particularly in comparison with the richness of our therapeutic repertoire. In this paper, I wish to apply a new, more physiological approach to cardiac contractile dysfunction based on investigation of the various steps in excitation-contraction coupling. To accomplish this, I focus rather narrowly on research from my own laboratory. Several excellent reviews summarize other aspects of the biology of ischemia and reperfusion.'-3 The reader is also referred elsewhere for discussion of the potentially important clinical manifestations of stunning and hibernation.4-6 Background
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The new sophistication in revascularization therapy for coronary artery disease has heightened our awareness of the diverse effects of perfusion on cardiac function. Total ischemia leads to a prompt cessation of contraction. 7 Reperfusion after periods of ischemia brief enough to prevent necrosis results in impaired contractile force generation, stunning, which persists for days to weeks after the ischemic event. 8, 9 The histological and metabolic abnormalities in stunned myocardium are relatively minor and provide few clues as to the origin of the dysfunction. Yet another manifestation of the effects of perfusion on contraction is myocardial hibernation,10,12 the The opinions expressed in this point of view are not necessarily those of the editors or of the American Heart Association. reversible contractile depression that occurs during a mild-to-moderate decrease in coronary perfusion. Considerable evidence favors the notion that force can respond to changes in flow even in the absence of ischemia ("Gregg's phenomenon"), but the mechanism remains unclear. 12 The distinctive features of myocardial stunning and hibernation are summarized in Table 1 .
Despite the rich variety of colloquialisms and eponyms that have evolved to describe the contractile abnormalities during ischemia and reperfusion, little is known about their pathophysiology at the cellular level. Do any of these conditions result from a failure of excitation? Is the availability of activator Ca21 decreased by other means, such as by impaired Ca21 release from the sarcoplasmic reticulum? Alternatively, is the myofilament responsiveness to Ca2+ reduced?
The various types of contractile dysfunction must involve changes in one or more steps of the final common pathway for contractile activation, depicted schematically in Figure 1 Figure  1D ). By combining the measurements of maximal Ca +-activated pressure with phosphorus-31 nuclear magnetic resonance (31P NMR) spectroscopy during hypoxia, we found that Pi accumulation, but not acidosis, correlated well with the observed contractile failure.21 Taken together, our results and those of Allen and Orchard15 imply that an accumulation of Pi, via its well-known inhibitory effect on crossbridge cycling, figures prominently in the pathogenesis of hypoxic contractile failure. In the same perfused heart model used for our measurements of maximal Ca2+-activated pressure, we recently confirmed the primacy of changes in Pi by verifying that Ca2+ transients are not decreased during relatively mild hypoxia. 22 Methodological Challenges in Intact Hearts In contrast to hypoxia, which can be induced in superfused muscles and cells, realistic models of myocardial stunning and hibernation require the use of perfused myocardial preparations. Both phenomena are readily demonstrable in in situ regional models,23-26 but isolated, perfused hearts allow considerably greater experimental flexibility. For stunned myocardium, whole-heart models have begun to clarify the nature of the impairment in excitation-contraction coupling. We found that the pressure developed by ferret hearts is decreased by 35% [27] [28] [29] We also found that maximal Ca2+-activated pressure is decreased ( Figure 1D ), but only by 20%; the decrease in maximal Ca2'-activated pressure thus contributes to, but cannot fully account for, the decrease in twitch force.27 A superimposed decrease in Ca21 transients ( Figure 1B ) and/or a shift in Ca21 sensitivity ( Figure 1C) was obtained under control perfusion conditions. The heart was then subjected to 15 minutes of total global ischemia at 37°C. After 20 minutes of reperfusion, the new developed pressure was approximately 40% lower than it had been in control; our previous research has shown that the contractile dysfunction produced by this intervention in the ferret heart fulfills the standard criteria for stunned myocardium. 27 What is remarkable here is that the Ca21 transients underlying this contractile dysfunction (B) are, if anything, greater than in control (A); the availability of cytoplasmic activator Ca21 is certainly not decreased in this postischemic heart.
Pooled data from seven hearts are summarized in Figure 3C . analysis of variance). The dashed vertical line demarcates coronary pressures of more than 60 mm Hg, at which energy metabolism is comparable to control, from those of 55 mm Hg or less, at which significant differences begin to occur. The range above 60 mm Hg is presumably where pure "hibernation" occurs, given the paucity of metabolic evidence of ischemia and the complete reversibility of the contractile changes at these pressures. The central abnormality of excitation-contraction coupling in hibernating myocardium is revealed in Figure 5 . this intervention thus satisfies the criteria described above for hibernating myocardium. Such changes in Ca2+ transients occurred consistently and were statistically significant.42
The results indicate that a decrease in Ca2+ transients underlies the contractile dysfunction of myocardial hibernation. Unlike stunned myocardium, no decrease in myofilament Ca2+ responsiveness need be postulated here.
With moderate decreases in perfusion pressure, as in Figure 5 
Limitations
Although the definition of stunning used here is generally accepted, there is little consensus in the literature regarding the meaning of hibernation. The term has been used to encompass dysfunction that may be associated with moderate or severe ischemia and exhibits only delayed reversibility.10"11,47-49 Taken to its logical extreme, the intuitive notion that hibernating myocardium is dysfunctional muscle that can be awakened by reperfusion, without lasting consequences, might even include the process of stunning. To avoid such potential overlap, I have chosen a pure but much more restrictive definition of hibernation than is commonly used. The distinction between stunning and hibernation becomes particularly problematic in classifying individual patients with coronary artery disease.5 Nevertheless, the features that characterize the ideal models may eventually help to distinguish stunning from hibernation in humans, as in vivo metabolic assay techniques (including, but not limited to, NMR spectroscopy) become more refined.
Given the important limitations of the 5F-BAPTA/ 
